Aberg N David, Johansson Ulf E, Aberg Maria A I, Hellström Nina A K, Lind Johan, Bull Cecilia, Isgaard Jörgen, Anderson Michelle F, Oscarsson Jan, Eriksson Peter S
Department of Internal Medicine, Research Center of Endocrinology and Metabolism, Sahlgrenska University Hospital, Göteborg University, Gröna Stråket 8, SE-413 45 Göteborg, Sweden.
Endocrinology. 2007 Aug;148(8):3765-72. doi: 10.1210/en.2006-1556. Epub 2007 May 17.
We have previously shown that recombinant human (rh) IGF-I induces cell proliferation and neurogenesis in the hippocampus of hypophysectomized rats. In the current investigation, we determined the effects of rhIGF-I on proliferation and differentiation in the cerebral cortex. Adult hypophysectomized rats were injected with bromodeoxyuridine (BrdU) to label newborn cells (once a day for the first 5 d), and rhIGF-I was administered peripherally for 6 or 20 d. In the cerebral cortex, the number of BrdU-labeled cells increased after 20 d but not after 6 d of rhIGF-I infusion. This suggests that rhIGF-I enhances the survival of newborn cells in the cerebral cortex. Using BrdU labeling combined with the oligodendrocyte-specific markers myelin basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase, we demonstrated an increase in oligodendrogenesis in the cerebral cortex. The total amount of myelin basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase was also increased on Western blots of homogenates of the cerebral cortex, confirming the immunohistochemical findings. Also, we observed an increase in the number of capillary-associated BrdU-positive cells, although total capillary area was not increased. rhIGF-I treatment did not affect cortical astrogliogenesis and neurogenesis was not observed. The ability of rhIGF-I to induce cortical oligodendrogenesis may have implications for the regenerative potential of the cortex.
我们之前已经表明,重组人(rh)胰岛素样生长因子-I(IGF-I)可诱导垂体切除大鼠海马中的细胞增殖和神经发生。在当前研究中,我们确定了rhIGF-I对大脑皮质增殖和分化的影响。对成年垂体切除大鼠注射溴脱氧尿苷(BrdU)以标记新生细胞(在最初5天每天注射一次),并对其外周给予rhIGF-I 6天或20天。在大脑皮质中,rhIGF-I输注20天后BrdU标记细胞的数量增加,但6天后未增加。这表明rhIGF-I可提高大脑皮质中新生细胞的存活率。使用BrdU标记结合少突胶质细胞特异性标志物髓鞘碱性蛋白和2',3'-环核苷酸3'-磷酸二酯酶,我们证明了大脑皮质中少突胶质细胞生成增加。大脑皮质匀浆的蛋白质免疫印迹也显示髓鞘碱性蛋白和2',3'-环核苷酸3'-磷酸二酯酶的总量增加,证实了免疫组织化学结果。此外,我们观察到与毛细血管相关的BrdU阳性细胞数量增加,尽管总毛细血管面积没有增加。rhIGF-I治疗不影响皮质星形胶质细胞生成,且未观察到神经发生。rhIGF-I诱导皮质少突胶质细胞生成的能力可能对皮质的再生潜力有影响。